Page 2 - Pathogen Panel News Today

The COVID-19 pandemic has caused an enormous need for testing and has spawned the creation of new labs and specimen collection agencies to try to meet that need.

The COVID-19 pandemic has caused an enormous need for testing and has spawned the creation of new labs and specimen collection agencies to try to meet that need.

To embed, copy and paste the code into your website or blog: On February 24, 2021, DOJ’s Criminal Division Fraud Section published its annual year-end summary (available here).  The Fraud Section focuses on prosecuting white-collar crime.  The report summarizes enforcement activity in the past year and discusses notable cases from the Fraud Section’s three litigation units:  (1) the Health Care Fraud (HCF) Unit; (2) the Foreign Corrupt Practices Act (FCPA) Unit; and (3) the Market Integr...

To embed, copy and paste the code into your website or blog: In a narrative that seems likely to be repeated in the coming year, the DOJ Healthcare Fraud Unit’s (HCF Unit) contribution to the Fraud Section’s 2020 Year in Review emphasized its enforcement action in three areas: Opioid epidemic COVID-19 With an entire year of healthcare delivery during a pandemic now behind us, and a new administration assessing its priorities, it is likely that the focus on each of these subjects will be bro...

Monday, March 8, 2021 On February 24, 2021, DOJ’s Criminal Division Fraud Section published its annual year-end summary (available here).  The Fraud Section focuses on prosecuting white-collar crime.  The report summarizes enforcement activity in the past year and discusses notable cases from the Fraud Section’s three litigation units:  (1) the Health Care Fraud (HCF) Unit; (2) the Foreign Corrupt Practices Act (FCPA) Unit; and (3) the Market Integrity and Major Frauds (MIMF) ...

Share this article Share this article AUSTIN, Texas, March 4, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a new expanded version of its NxTAG ® Respiratory Pathogen Panel (RPP) that includes the SARS-CoV-2 virus for high-throughput respiratory testing. The new test is a combination of the companys original NxTAG RPP, an FDA-cleared in vitro diagnostic for synd...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York ProPhase Labs, Inc.January 29, 2021 GMT - Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the opening of its 25,000 squa...

ProPhase Labs, Inc. Announces Closing of Public Offering January 21, 2021 16:30 ET | Source: ProPhase Labs, Inc. ProPhase Labs, Inc. DOYLESTOWN, Pennsylvania, UNITED STATES Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced public offering of 3,000,000 shares of its common stock at a public offering price ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.